Genetic determinants of cardiovascular disease in patients with obstructive sleep apnea (OSA)

Piotr Bielicki (Warsaw, Poland), Piotr Bielicki, Malgorzata Barnas, Kamil Brzoska, Luiza Jonczak, Robert Plywaczewski, Marta Kumor, Tomasz Stepkowski, Ryszarda Chazan, Marcin Kruszewski, Pawel Sliwinski

Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing
Session: Ring of fire: inflammation and metabolism in sleep-disordered breathing
Session type: Oral Presentation
Number: 1751
Disease area: Sleep and breathing disorders

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Piotr Bielicki (Warsaw, Poland), Piotr Bielicki, Malgorzata Barnas, Kamil Brzoska, Luiza Jonczak, Robert Plywaczewski, Marta Kumor, Tomasz Stepkowski, Ryszarda Chazan, Marcin Kruszewski, Pawel Sliwinski. Genetic determinants of cardiovascular disease in patients with obstructive sleep apnea (OSA). Eur Respir J 2015; 46: Suppl. 59, 1751

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Association between smoking and concomitant diseases in obstructive sleep apnoea (OSA)
Source: International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II
Year: 2015

Albuminuria in moderate and severe obstructive sleep apnoea (OSA) patients
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015

Prevalence of arterial hypertension in obstructive sleep apnoea (OSA) patients – Impact of diabetes and obesity
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013


The effects of obstructive sleep apnea on cardiovascular functioning in children with obesity
Source: Annual Congress 2013 –Assessing sleep disordered breathing and lung function in children
Year: 2013

Evaluation of lipid profile in patients with obstructive sleep apnea syndrome
Source: International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II
Year: 2015


Subclinical atherosclerosis in obstructive sleep apnea (OSA): The EPIOSA study
Source: International Congress 2015 – Paediatric and adult sleep-disordered breathing: from inflammation to treatment and telemedicine
Year: 2015

The investigation of relationship between red cell distribution width and cardiovascular diseases in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2013 –Sleep disordered breathing in special situations I
Year: 2013

Effects of age on severity of disease in an obstructive sleep apnea population
Source: Annual Congress 2013 –Sleep disordered breathing in special situations II
Year: 2013


Use of clinical predictors on diagnosis of OSAS in patients with chronic obstructive pulmonary disease, asthma and cardiovascular diseases
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014


Transition from obstructive sleep apnea (OSA) to obesity hypoventilation syndrome (OHS)
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies
Year: 2015


Influence of smoking on sleep and disease severity in a population of obstructive sleep apnea patients
Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease
Year: 2013


Gender differences in comorbidity burden in recently diagnosed obstructive sleep apnea patients
Source: International Congress 2014 – Sleep disordered breathing 1
Year: 2014

Prevalence of obstructive sleep apnea syndrome in patients with risk factors for cardiovascular diseases in a large population in Zaragoza (Spain)
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014


Phenotyping comorbidity in obstructive sleep apnea syndrome
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults II: questionnaires, epidemiology and sleep studies
Year: 2015

Obstructive sleep apnea syndrome (OSA) and hypercoagulability – What is the impact of sole OSA in the absence of comorbities?
Source: Annual Congress 2013 –Sleep disordered breathing in special situations I
Year: 2013

Correlations between cardiovascular diseases and diabetes in obstructive sleep apnoea (OSA)
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012

Prevalence of hyperuricemia in patients with obstructive sleep apnea from the Mallorca cohort
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014


Association between obstructive sleep apnoea (OSA) severity and metabolic disturbances
Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Year: 2017

Progression of subclinical atherosclerosis in obstructive sleep apnoea (OSA)
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016

Differences in prevalence of metabolic syndrome (MS) between male and female patients with moderate and severe obstructive sleep apnea. The definition is certainly an important factor
Source: International Congress 2014 – Sleep disordered breathing 4
Year: 2014